Table of contents
- Vitamin D's Role in Reducing Risk of SARS-CoV-2 and COVID-19 Incidence, Severity, and Death
- VitaminDWiki - Calcifediol and Virus studies (7 as of Dec 2021)
- VitaminDWiki - some Calcifediol studies (5 as of Dec 2021)
- VitaminDWiki - 40 most-recently changed items in Virus Category
- VitaminDWiki - COVID-19 treated by Vitamin D - studies, reports, videos
- 55+ VitaminDWiki pages have GRANT but not MIGRANT in title
- VitaminDWiki - Vitamin D meta-analyses for Virus
Vitamin D's Role in Reducing Risk of SARS-CoV-2 and COVID-19 Incidence, Severity, and Death
Nutrients 2022, 14, 183. https://doi.org/10.3390/nu14010183
William B. Grant Sunlight, Nutrition and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, USA; williamgrant08@comcast.net; Tel.: +1-415-409-1980
The article by D'Avolio and colleagues [1] on patients with a positive polymerase chain reaction (PCR) test for SARS-CoV-2 was the first to report that 25-hydroxyvitamin D [25(OH)D] concentrations were lower in PCR-positive patients than in PCR-negative patients or in historical controls. As a result, that report has the most citations in its category (201 according to SCOPUS on 17 December 2021). Thus, the article likely helped considerably stimulate investigation of vitamin D's role in reducing risk of SARS-CoV-2 infection and ensuing COVID-19.
A later article on 25(OH)D concentration and risk of SARS-CoV-2 positivity was based on more than 190,000 PCR tests on patients in the U.S. with serum 25(OH)D concentration measurements from the previous 12 months on file by quest diagnostics [2]. According to that report, positivity was inversely correlated with seasonally adjusted 25(OH)D concentration, posing a risk for patients with concentrations of ~55 ng/mL have about half the positivity of those with concentrations of <20 ng/mL.
A recent meta-analysis involving 76 studies reported inverse correlations for COVID- 19 risk with respect to serum 25(OH)D concentrations for risk of developing the disease, its severity, and risk of death [3], thus offering support for the role of vitamin D in reducing risk of COVID-19.
However, because of the concern that having an acute inflammatory illness could lower serum 25(OH)D concentrations [4], observational studies of COVID-19 using 25(OH)D concentrations measured at or near time of diagnosis have been questioned. The data in Figure 3 of reference [3] can be used to address that concern.
The 19 studies can be divided into four categories:
- 25(OH)D at time of diagnosis (seven studies);
- within 1 year prior (eight);
- preceding 10 years (one); and
- 10-15 years prior (three).
The mean weighted odds ratios for each time are 2.08,1.76,1.27, and 1.04, respectively. Those values are consistent with a longer interval between blood draw and health outcome, which are associated with worse health outcomes due to changes in 25(OH)D concentrations. That effect is most pronounced for diseases that can develop rapidly, such as breast cancer [5]. Although the present editorial does not rule out reduction in 25(OH)D due to COVID-19, the times before diagnosis are independent of COVID-19 and support the role of vitamin D in reducing risk.
The innate immune system mechanisms by which vitamin D reduces risk of SARS- CoV-2 infection and COVID-19 appear to include reduced viral viability and replication by inducing cathelicidin and defensins as well as reduced production of proinflammatory cytokines and the risk of the cytokine storm [6]. Additional mechanisms were suggested later [7]. The innate immune system is not sensitive to the variant of SARS-CoV-2 involved. That is important because the virus mutates easily, thereby reducing the adaptive immune system's ability to respond effectively. Thus, vitamin D can serve as an extra measure of protection as vaccine effectiveness wanes. The recommended serum 25(OH)D concentration for prevention is 40 to >60 ng/mL, which could be achieved with 5000 to 10,000 IU/d vitamin D3, i.e., a safe dose range [8].
Thus, it seems likely that raising serum 25(OH)D concentrations after SARS-CoV- 2 infection or development of COVID-19 could reduce the progression and severity of COVID-19. Two approaches were attempted with mixed results. The most comprehensive trial of vitamin D3 supplementation with COVID-19 patients was a trial conducted in Turkey [9]. Of 867 COVID-19 patients, 160 patients with initial 25(OH)D concentrations of <30 ng/mL were treated with 224,000 to 500,000 IU over periods from 3 to 7 days to achieve >30 ng/mL. The only clinically significant benefit in comparison with untreated patients with 25(OH)D <30 ng/mL was a reduction in hospital stays over 8 days. However, the length of hospital stay was not significantly different between the two groups. That trial probably failed to achieve significant beneficial effects because the body takes several days to convert vitamin D to 25(OH)D, during which time the disease progresses, and because the achieved 25(OH)D concentrations were only 32 ± 12 ng/mL on day 7 and 36 ± 11 ng/mL on day 14.
An alternate approach is to supplement with calcifediol [25(OH)D], which raises serum 25(OH)D concentrations in hours. A successful pilot randomized controlled trial of calcifediol treatment was reported from Barcelona in 2020 [10]. That trial included 76 consecutive COVID-19 patients with acute respiratory tract infection and a positive PCR test for SARS-CoV-2. In addition to standard hospital care, 50 patients were assigned to receive calcifediol treatment: 0.532 mg on the first day, 0.266 mg on days 3 and 7, and then weekly until discharge or ICU admission. Calcifediol is about 3.2 times more efficient at raising serum 25(OH)D concentrations than vitamin D3 [11]. Thus, 0.266 mg of calcifediol is equivalent to ~34,000 IU of vitamin D3. Only 1 of 50 patients treated with calcifediol required ICU treatment, as opposed to 13 of 26 not receiving calcifediol (2 of whom died).
An observational study in Spain involved 537 patients hospitalized with COVID-19 between 5 February and 5 May 2020, of whom 79 were treated with calcifediol [12]. The odds ratio for mortality within 30 days, adjusted for potential confounders, was 0.16 (95% confidence interval, 0.03 to 0.80).
 Download the PDF from VitaminDWiki
References
- D'Avolio, A.; Avataneo, V.; Manca, A.; Cusato, J.; De Nicolo, A.; Lucchini, R.; Keller, F.; Cantu, M. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients 2020,12,1359. [CrossRef] PDF
- Kaufman, H.W.; Niles, J.K.; Kroll, M.H.; Bi, C.; Holick, M.F. SARS-CoV-2 positivity rates associated with circulating 25- hydroxyvitamin D levels. PLoS ONE 2020,15, e0239252. [CrossRef]
In VitaminDWiki Rate of COVID-19 test positive is 40 pcnt lower if high vitamin D (192,000 people) - Holick Sept 2020
- Dissanayake, H.A.; de Silva, N.L.; Sumanatilleke, M.; de Silva, S.D.N.; Gamage, K.K.K.; Dematapitiya, C.; Kuruppu, D.C.; Ranasinghe, P.; Pathmanathan, S.; Katulanda, P. Prognostic and therapeutic role of vitamin D in COVID-19: Systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2021, dgab892. [CrossRef]
- Smolders, J.; van den Ouweland, J.; Geven, C.; Pickkers, P.; Kox, M. Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence. Metabolism 2021,115,154434. [CrossRef]
- Grant, W.B. Long follow-up time and different sensitivities of cancer types may have obscured the effect of 25-hydroxyvitamin D on cancer incidence and mortality rates. Am. J. Clin. Nutr. 2015,102, 230. [CrossRef]
- Grant, W.B.; Lahore, H.; McDonnell, S.L.; Baggerly, C.A.; Franch, C.B.; Aliano, J.L.; Bhattoa, H.P. Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020,12, 988. [CrossRef]
- Mercola, J.; Grant, W.B.; Wagner, C.L. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020, 12, 3361. [CrossRef] [PubMed]
- McCullough, P.J.; Lehrer, D.S.; Amend, J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience. J. Steroid Biochem. Mol. Biol. 2019,189, 228-239. [CrossRef] [PubMed]
- Gonen, M.S.; Alaylioglu, M.; Durcan, E.; Ozdemir, Y.; Sahin, S.; Konukoglu, D.; Nohut, O.K.; Urkmez, S.; Kucukece, B.; Balkan, I.I.; et al. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients 2021,13, 4047. [CrossRef]
- Entrenas-Castillo, M.; Entrenas Costa, L.M.; Vaquero Barrios, J.M.; Alcala Diaz, J.F.; Lopez Miranda, J.; Bouillon, R.; Quesada Gomez, J.M. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J. Steroid Biochem. Mol. Biol. 2020, 203,105751. [CrossRef] [PubMed]
- Quesada-Gomez, J.M.; Bouillon, R. Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos. Int. 2018, 29,1697-1711. [CrossRef] [PubMed]
- Alcala-Diaz, J.F.; Limia-Perez, L.; Gomez-Huelgas, R.; Martin-Escalante, M.D.; Cortez-Rodriguez, A.L.; Lopez-Carmona, M.D. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study. Nutrients 2021,13,1760. [CrossRef] [PubMed]
VitaminDWiki - Calcifediol and Virus studies (7 as of Dec 2021)
- Calcifediol (semi-activated Vitamin D) might treat Respiratory Diseases such as COVID - July 2022
- Two times less likely to test positive for COVID if vitamin D level more than 55ng, etc. – Dec 31, 2021
- Large dose of calcifediol or vitamin D up to 15 days before COVID hospitalization reduced death rates (1.5X, 1.3X) – Dec 2021
- Vitamin D trial for COVID-19 – using their patented slow-release form – Aug 2021
- COVID-19 death 40 percent less likely if supplemented with Vitamin D and got above 30 ng (Spain 108,000 people) – July 2021
- 7X less likely to go to ICU if COVID-19 ward gave calcifediol (semi-activated Vitamin D) – July 2021
- 5X less likely to enter ICU with COVID-19 if get Calcifediol (semi-activated vitamin D) - RCT Feb 19, 2021
- COVID-19 defeated by calcifediol form of Vitamin D in Spain - pilot RCT Aug 29, 2020
VitaminDWiki - some Calcifediol studies (5 as of Dec 2021)
- Calcifediol (Calcidiol) is far less cost-effective and available than Vitamin D – RCT June 2021
- Calcidiol (Calcifediol, ampli-D) approved as food supplement by EFSA – (10 micrograms per day) – July 2021
- Weekly response to semi-activated vitamin D slightly better than standard – RCT Nov 2019
- Semi-activated Vitamin D given weekly (used by Spanish COVID-19 trial) – US patent application Sept 2020
- Vitamin D3 becomes Calcidiol which becomes Calcitriol
VitaminDWiki - 40 most-recently changed items in Virus Category
VitaminDWiki - COVID-19 treated by Vitamin D - studies, reports, videos
As of March 31, 2024, the VitaminDWiki COVID page had: trial results, meta-analyses and reviews, Mortality studies see related: Governments, HealthProblems, Hospitals, Dark Skins, All 26 COVID risk factors are associated with low Vit D, Fight COVID-19 with 50K Vit D weekly Vaccines Take lots of Vitamin D at first signs of COVID 166 COVID Clinical Trials using Vitamin D (Aug 2023) Prevent a COVID death: 9 dollars of Vitamin D or 900,000 dollars of vaccine - Aug 2023
5 most-recently changed Virus entries
55+ VitaminDWiki pages have GRANT but not MIGRANT in title
This list is automatcially updated
VitaminDWiki - Vitamin D meta-analyses for Virus
- COVID ICU use reduced by 42% if take more than 100,000 IU of vitamin D over two weeks – meta-analysis Sept 2024
- Vaccinations did not stop COVID (68 studies) – meta-analysis May 2023
- Influenza risk cut in half by the only trial giving enough vitamin D for body weight – meta-analysis Jan 2022
- Multiple Vitamin D doses reduced COVID ICU by 2.5 X , Mech. Ventilation by 5.5 X – meta-analysis May 2024
- COVID death rate in hospital halved if take any amount of vitamin D for any length of time – meta-analysis May 2024
- COVID and Vitamin D: 2X more likely to die if low, 2X more likely to survive if supplement – umbrella meta-analysis April 2024
- COVID fought by Vitamin D: 2.3X less likely to die of COVID if supplemented, 1.9 X less likely to become infected – meta-analysis March 2024
- COVID Vaccinations increased risk of cardiac deaths in youths by 19% - Aug 2023
- T1 Diabetes increased by 27% by second year of COVID – meta-analysis June 2023
- Yet another reason to take Vitamin D while pregnant – fight COVID - meta-analysis May 2023
- COVID death 1.5 X less likely if high vitamin D, emergency D (50K to 100K) is great – meta-analysis March 2023
- COVID ICU 3X less-likely if take any amount and type of Vitamin D – meta-analysis Jan 2023
- COVID and Vitamin D: any amount of D, at any time, for any duration reduced ICU - meta-analysis Dec 2022
- Worse COVID during 3Q pregnancy if 2.5 ng lower Vitamin D – meta-analysis Sept 2022
- Severe COVID 2.6 X less likely if supplement with Vitamin D – 26th meta-analysis - July 2022
- COVID Long-Haul prevalence increases with time: 50% at 4 months - meta June 2022
- COVID test positive is about half as likely if have Vitamin D – 24th meta-analysis - Jan 2022
- Small amounts of Vitamin D reduce Influenza risk by 22 percent (loading dose is far better) – meta-analysis Jan 2022
- Vitamin D fights COVID (54 studies of 1,400,000 people) – 23rd meta-analysis - Dec 2021
- COVID-19 treated by Vitamin D (reduce ICU by 3X) - 22nd meta-analysis - Dec 29, 2021
- COVID-19 death increased 2X if low Vitamin D (less than 10 to less than 30 ng) – 21st meta-analysis Dec 2021
- COVID-19 risk reduced by vitamin D supplementation – umbrella review of 7 meta-analysis – Oct 2021
- COVID-19 treated by Vitamin D (example: ICU reduced by 5X) – 20th meta-analysis Oct 13, 2021
- Severe COVID-19 2.5 X more likely if low vitamin D (23 studies) – 19th meta-analysis Oct 2021
- COVID-19 mortality extrapolates to zero at 50 ng of vitamin D – 18th Meta-analysis Sept 2021
- COVID-19 death 1.6 X more likely if low vitamin D (24 studies) – 17th meta-analysis Aug 2021
- Severe COVID-19 5X more likely if low vitamin D (23 studies) – 16th meta-analysis July 2021
- Severe COVID-19 3.5 more likely if low vitamin D (30 studies) – meta-analysis July 2021
- COVID-19 patients who had supplemented with Vitamin D were 3X less likely to enter ICU – June 2021
- Low Calcium associated with severe COVID-19 – several studies
- COVID-19 mortality 3X more likely if low vitamin D (999,179 people) – meta-analysis March 29, 2021
- COVID-19 was 2.6X more severe if very low Vitamin D (43 studies) – meta-analysis March 26, 2021
- Low Vitamin D associated with 2.7X more severe COVID-19 – 12th MA March 5, 2021
- Vitamin D supplementation fights COVID-19 – 11th meta-analysis Jan 24, 2021
- 3.7 X less likely to die of COVID-19 if supplemented with Vitamin D - meta-analysis Jan 5, 2021
- Less likely to test positive for COVID-19 if higher Vitamin D – meta-analysis Jan 6, 2021
- Vitamin D reduces COVID-19 by 80 percent - anonymous meta-analysis - Jan 5, 2021
- COVID-19 1.7X more likely to be severe if low Vitamin D - meta-analysis Oct 2020
- Low Vitamin D associated 1.8X increased risk of COVID-19 death in hospital – meta-analysis Nov 4, 2020
- Acute viral respiratory infections (RTI) reduced by Vitamin D - 20 reviews - Aug 2020
- Prudent to consider that Vitamin D has a role in COVID-19 – meta-analysis – Aug 7, 2020
- Risk of enveloped virus infection is increased 50 percent if poor Vitamin D Receptor - meta-analysis Dec 2018
- Hepatitis B patients have 2 ng lower level of Vitamin D – meta-analysis June 2019
- Influenza Vaccination not benefited by lowish levels of vitamin D – meta-analysis March 2018